Casma Therapeutics to Present at the Gordon Research Conference on Autophagy in Stress, Development, and Disease

CAMBRIDGE, Mass., February 28, 2024– Casma Therapeutics, Inc., a biotechnology company engaging the autophagy/lysosomal system to provide innovative new medicines, today announced that Leon Murphy, Ph.D., Chief Scientific Officer and Dan Baird Ph.D., Vice President, Molecular Discovery will participate in the Gordon Research Conference on Autophagy in Stress, Development, and Disease in Lucca, Italy. Dr. […] The post Casma Therapeutics to Present at the Gordon Research Conference on Autophagy in Stress, Development, and Disease appeared first on Casma Therapeutics .